Quick Takeaways
- Bleichroeder LP filed SCHEDULE 13G/A for Cellectar Biosciences, Inc. Common Shares (CLRB).
- Disclosed ownership: 4.6%.
- Date of event: 31 Dec 2025.
Bleichroeder LP - 31 Dec 2025 SCHEDULE 13G/A Report for Cellectar Biosciences, Inc. Common Shares (CLRB)
- Filing Manager
- Bleichroeder LP
- Reporting Manager
- Bleichroeder LP
- Symbol
- CLRB
- Shares outstanding
- 4,338,395 shares
- Disclosed Ownership
- 200,000 shares
- Ownership
- 4.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Feb 2026, 16:44:33 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Bleichroeder LP disclosed 4.6% ownership in Cellectar Biosciences, Inc. Common Shares (CLRB) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 13 Feb 2026, 16:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Bleichroeder LP | 4.6% | 200,000 | 200,000 | 0 | Andrew Gundlach | President and CEO | |
| Bleichroeder Holdings LLC | 4.6% | 200,000 | 200,000 | 0 | Andrew Gundlach | President and CEO | |
| Andrew Gundlach | 4.6% | 200,000 | 200,000 | 0 | Andrew Gundlach | Individual |